RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Huaren Pharmaceutical Co Stock

Huaren Pharmaceutical Co Equity 2025

Huaren Pharmaceutical Co Equity

2.69 B CNY

Ticker

300110.SZ

ISIN

CNE100000SW1

In 2025, Huaren Pharmaceutical Co's equity was 2.69 B CNY, a 6.45% increase from the 2.53 B CNY equity in the previous year.

Huaren Pharmaceutical Co Aktienanalyse

What does Huaren Pharmaceutical Co do?

Huaren Pharmaceutical Co. Ltd is a leading Chinese pharmaceutical company based in Beijing. It was founded in 1996 and has since experienced impressive growth. The company is listed on the Shanghai Stock Exchange under the ticker symbol SHA:600664. Huaren Pharmaceutical's history is characterized by a smart corporate strategy and a strong focus on customer needs. The company started as a small family business and built a strong presence in the Chinese market in the following years. This involved establishing innovative strategic partnerships with other companies in the industry. In 2010, the company went public, further accelerating its growth. The business model of Huaren Pharmaceutical is based on a wide product portfolio, including various products in the pharmaceutical, healthcare, and biotechnology industries. The company works closely with international experts and scientific institutes to ensure the highest quality and effectiveness of its products. It is active in research and development, production, and distribution of healthcare products and services, and has built strong industry expertise. The different divisions of Huaren Pharmaceutical include the production of antibiotics, vitamin complexes, painkillers, and vaccines. The company is also involved in diagnostic, hospital care, and medical device sectors. Another important division is the production of generics, which makes the company one of the major players in the Chinese generic drug market. Huaren Pharmaceutical takes pride in providing a comprehensive range of products for patients. Its key products include anti-cancer therapies, medications for nervous system disorders, cardiovascular diseases, and vascular diseases. The company has state-of-the-art research and development departments that ensure its products are always at the forefront of technology and meet customer needs. Due to its innovation capabilities, Huaren Pharmaceutical has won numerous awards and patents. The company aims to solidify its market leadership in China while expanding its presence in the Asian and global pharmaceutical markets. It also intends to focus on the biotechnology market and expand its research and development activities. With this strategic approach, Huaren Pharmaceutical aims to remain a significant player in the Chinese pharmaceutical industry and drive advancements and technologies in healthcare. Huaren Pharmaceutical Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing Huaren Pharmaceutical Co's Equity

Huaren Pharmaceutical Co's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Huaren Pharmaceutical Co's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Huaren Pharmaceutical Co's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Huaren Pharmaceutical Co's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Huaren Pharmaceutical Co’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Huaren Pharmaceutical Co stock

What is the equity of Huaren Pharmaceutical Co this year?

Huaren Pharmaceutical Co has equity of 2.69 B CNY this year.

What was the equity of Huaren Pharmaceutical Co compared to the previous year?

The equity of Huaren Pharmaceutical Co has increased/decreased by 6.45% increased compared to the previous year.

What impact does a high equity have on investors of Huaren Pharmaceutical Co?

A high equity is advantageous for investors of Huaren Pharmaceutical Co as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Huaren Pharmaceutical Co?

A low equity can be a risk for investors of Huaren Pharmaceutical Co, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Huaren Pharmaceutical Co affect the company?

An increase in equity of Huaren Pharmaceutical Co can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Huaren Pharmaceutical Co affect the company?

A reduction in equity of Huaren Pharmaceutical Co can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Huaren Pharmaceutical Co?

Some factors that can affect the equity of Huaren Pharmaceutical Co include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Huaren Pharmaceutical Co so important for investors?

The equity of Huaren Pharmaceutical Co is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Huaren Pharmaceutical Co take to change the equity?

To change equity, Huaren Pharmaceutical Co can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Huaren Pharmaceutical Co pay?

Over the past 12 months, Huaren Pharmaceutical Co paid a dividend of 0.02 CNY . This corresponds to a dividend yield of about 0.65 %. For the coming 12 months, Huaren Pharmaceutical Co is expected to pay a dividend of 0.02 CNY.

What is the dividend yield of Huaren Pharmaceutical Co?

The current dividend yield of Huaren Pharmaceutical Co is 0.65 %.

When does Huaren Pharmaceutical Co pay dividends?

Huaren Pharmaceutical Co pays a quarterly dividend. This is distributed in the months of July, July, August, August.

How secure is the dividend of Huaren Pharmaceutical Co?

Huaren Pharmaceutical Co paid dividends every year for the past 7 years.

What is the dividend of Huaren Pharmaceutical Co?

For the upcoming 12 months, dividends amounting to 0.02 CNY are expected. This corresponds to a dividend yield of 0.65 %.

In which sector is Huaren Pharmaceutical Co located?

Huaren Pharmaceutical Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Huaren Pharmaceutical Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Huaren Pharmaceutical Co from 7/10/2024 amounting to 0.021 CNY, you needed to have the stock in your portfolio before the ex-date on 7/10/2024.

When did Huaren Pharmaceutical Co pay the last dividend?

The last dividend was paid out on 7/10/2024.

What was the dividend of Huaren Pharmaceutical Co in the year 2024?

In the year 2024, Huaren Pharmaceutical Co distributed 0.018 CNY as dividends.

In which currency does Huaren Pharmaceutical Co pay out the dividend?

The dividends of Huaren Pharmaceutical Co are distributed in CNY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Huaren Pharmaceutical Co

Our stock analysis for Huaren Pharmaceutical Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Huaren Pharmaceutical Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.